Evolving Class of Drugs Advances Treatment for Autoimmune Disorders
Dr. Veena Ranganath, as featured in UCLA Health Vital Sign publication and video, talks about how treatment for rheumatoid arthritis has evolved dramatically in recent years due the growing availability of biologic therapies. Return to Rheumatology Homepage
UCLA Undergraduate student Darshan Randhawa received Undergraduate Research Scholar Wasserman Award to study a new mechanism of inflammation in patients with lupus and vasculitis in the laboratory of Dr. Ram Raj Singh at UCLA Division of Rheumatology. He will determine whether changes in a blood cell called neutrophil cause increase in cytokines that perpetuate inflammation in these patients. Mr. Randhawa is applying medical schools to pursue MD, PhD. We hope that his training as an undergraduate will lure him to rheumatology fellowship and discover new treatments for inflammatory diseases. Your investment for their stipend and research expenses may go a long way in realize that students like Randhawa become your future rheumatologists.
UCLA Division of Rheumatology junior faculty Isela Valera, PhD, received a National Institutes of Health (NIH) K01 grant to understand the cause for lung disease in patients with scleroderma and other rheumatic diseases in the laboratory of Dr. Ram Raj Singh. She will specifically investigate why males with scleroderma have more lung damage than females that are more susceptible initially to develop the disease. NIH K01 grant provides salary, but limited research fund. We need your investment in young scientists like Isela to make a difference in scleroderma and other diseases, to march towards finding the first FDA-approved drug for this disease, and to eventually find its cure.
American College of Rheumatology Annual Meeting 2012 Schedule of Events.See schedule »
2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis.Learn more »
The Rheumatologist features ACR Guidelines for Gout Management The ACR's first guidelines for management of gout, published this fall, can serve as a road map for clinicians, with guidance on treatment decisions based on nine different case scenarios. The guidelines are in two parts: Part I on systematic nonpharmacologic and pharmacologic therapy of hyperuricemia, and Part II on therapy and antiinflammatory prophylaxis of acute gouty arthritis. Read more »
American College of Rheumatology Issues Report on Musculoskeletal Ultrasound in Rheumatology Clinical Practice. View report »
American College of Rheumatology Issues New Guidelines for Management of Gout.View report »
American College of Rheumatology Issues New Guidelines for Screening, Treating Severe Lupus. View report »
New Guidelines Issued for Severe Lupus (HealthDay News) When diagnosed with lupus, one in three people already has kidney inflammation, and during the first 10 years with the disease as many as 60 percent of patients will have some kidney problems. Article features comments by Dr. Bevra Hahn. Read more »
New Guidelines Issued for Severe Lupus (WebMD ) When lupus attacks the kidneys, the damage can be life-threatening. Now, updated guidelines from the American College of Rheumatology are aimed at identifying kidney involvement in lupus early and treating it aggressively to stop this damage in its tracks. Article features comments by Dr. Bevra Hahn. Read more »
Lupus Nephritis: New Guidance for Rheumatologist The American College of Rheumatology has issued new guidelines on the latest in treatment for lupus nephritis. In this podcast, the head of the guidelines panel, Bevra Hahn, MD, discusses the highlights of the guidelines. Features comments by Dr. Bevra Hahn. Read more »
Frontiers of Rheumatology- 30th Annual Pearson Symposium The 30th Carl M Pearson Symposium, held in Marina Del Rey Marriott on April 27th - 29th attracted over 150 attendees across the Southern California community including rheumatologists, interested physicians health care professionals and rheumatology fellows. Learn more»
Trailblazer in Rheumatology(The Rheumatologist) Since the beginning of their medical careers, Rodanthi C. Kitridou, MD, and Bevra H. Hahn, MD, have seen a huge shift in the demographics of the field. Read more »